Treatment of central nervous system disorders by use of PDGF or VEGF

Details for Australian Patent Application No. 2002334327 (hide)

Owner NeuroNova AB

Inventors Plate, Karlheinz; Janson, Ann, Marie; Schanzer, Anne; Kuhn, Georg, H.; Zhao, Ming; Delfani, Kioumars; Wachs, Frank-Peter

Agent Cullen & Co

Pub. Number AU-B-2002334327

PCT Number PCT/IB02/03998

PCT Pub. Number WO2003/024478

Priority 60/323,381 19.09.01 US; 60/326,044 28.09.01 US

Filing date 19 September 2002

Wipo publication date 1 April 2003

Acceptance publication date 4 May 2006

International Classifications

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

13 February 2003 Complete Application Filed

  Priority application(s): 60/323,381 19.09.01 US; 60/326,044 28.09.01 US

5 June 2003 Application Open to Public Inspection

  Published as AU-B-2002334327

4 May 2006 Application Accepted

  Published as AU-B-2002334327

31 August 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002334328-SERVICE INFORMATION MULTICASTING METHOD AND SYSTEM

2002334326-Extended release pharmaceutical composition containing metformin